Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis

NCT05796401 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Psychosis

Interventions

BEHAVIORAL: Cognitive training
DRUG: Personalized neuroprotective strategies : Vitamin B12, folinic acid, Omega 3, NAC
OTHER: Treatment as usual (TAU)

Sponsor

Centre Hospitalier St Anne